Payment overview · 2025
General Payments
$39.52
2 reported records · 2 companies
Healthcare provider profile · identity verified
David Paul Kimmel, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BANNER ELK, NC · NPI 1053306092
Verified facts
What the public records show
CMS Open Payments records show David Paul Kimmel, MD received $39.52 in general payments during 2025 across 2 reported records.
CSL Behring accounted for 65.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 123 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| CSL Behring | Unresolved — no canonical attribution shown | $26.03 | 65.9% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $13.49 | 34.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $39.52 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Hizentra Normalized: hizentra |
Biological | CSL Behring | $26.03 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $13.49 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $13.49 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 123 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
123 | 22 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 532 | 107 |
| Losartan Potassium | Losartan Potassium | 452 | 117 |
| Omeprazole | Omeprazole | 429 | 134 |
| Amlodipine Besylate | Amlodipine Besylate | 406 | 110 |
| Levothyroxine Sodium | Levothyroxine Sodium | 399 | 122 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 389 | 113 |
| Eliquis | Apixaban | 368 | 67 |
| Atorvastatin Calcium | Atorvastatin Calcium | 335 | 97 |
| Pantoprazole Sodium | Pantoprazole Sodium | 317 | 88 |
| Clonazepam | Clonazepam | 273 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 269 | 77 |
| Oxycodone Hcl | Oxycodone Hcl | 219 | 36 |
| Metformin Hcl | Metformin Hcl | 216 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 211 | 57 |
| Fluticasone Propionate | Fluticasone Propionate | 211 | 67 |
| Alprazolam | Alprazolam | 209 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 204 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 204 | 63 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 195 | 37 |
| Tramadol Hcl | Tramadol Hcl | 193 | 34 |
| Lisinopril | Lisinopril | 192 | 50 |
| Famotidine | Famotidine | 186 | 53 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 179 | 47 |
| Furosemide | Furosemide | 178 | 47 |
| Pravastatin Sodium | Pravastatin Sodium | 166 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 164 | 50 |
| Zolpidem Tartrate | Zolpidem Tartrate | 163 | 30 |
| Trazodone Hcl | Trazodone Hcl | 158 | 45 |
| Mirtazapine | Mirtazapine | 153 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 152 | 39 |
| Simvastatin | Simvastatin | 149 | 38 |
| Indapamide | Indapamide | 138 | 42 |
| Allopurinol | Allopurinol | 135 | 38 |
| Doxycycline Hyclate | Doxycycline Hyclate | 135 | 104 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 131 | 31 |
| Duloxetine Hcl | Duloxetine Hcl | 129 | 29 |
| Ozempic | Semaglutide | 123 | 22 |
| Sertraline Hcl | Sertraline Hcl | 113 | 29 |
| Meloxicam | Meloxicam | 112 | 33 |
| Xarelto | Rivaroxaban | 112 | 16 |
| Carvedilol | Carvedilol | 111 | 34 |
| Prednisone | Prednisone | 107 | 48 |
| Azithromycin | Azithromycin | 104 | 77 |
| Lorazepam | Lorazepam | 104 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 101 | 21 |
| Potassium Chloride | Potassium Chloride | 99 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 96 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 94 | 13 |
| Montelukast Sodium | Montelukast Sodium | 87 | 27 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 86 | 11 |
| Synthroid | Levothyroxine Sodium | 83 | 20 |
| Farxiga | Dapagliflozin Propanediol | 82 | 16 |
| Diazepam | Diazepam | 81 | 19 |
| Ezetimibe | Ezetimibe | 79 | 17 |
| Ondansetron Odt | Ondansetron | 78 | 24 |
| Spironolactone | Spironolactone | 77 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 76 | 25 |
| Warfarin Sodium | Warfarin Sodium | 76 | 17 |
| Baclofen | Baclofen | 74 | 12 |
| Finasteride | Finasteride | 72 | 16 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 70 | 18 |
| Morphine Sulfate Er | Morphine Sulfate | 69 | suppressed |
| Glimepiride | Glimepiride | 68 | 18 |
| Fluconazole | Fluconazole | 67 | 34 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 67 | 20 |
| Pregabalin | Pregabalin | 67 | 15 |
| Valsartan | Valsartan | 67 | 25 |
| Buspirone Hcl | Buspirone Hcl | 64 | 16 |
| Myrbetriq | Mirabegron | 64 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 62 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 61 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 59 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 58 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 58 | 39 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 57 | 11 |
| Sucralfate | Sucralfate | 55 | 21 |
| Symbicort | Budesonide/Formoterol Fumarate | 55 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 54 | 18 |
| Bupropion Hcl | Bupropion Hcl | 51 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 51 | suppressed |
| Temazepam | Temazepam | 51 | suppressed |
| Cefdinir | Cefdinir | 49 | 42 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 49 | 11 |
| Cephalexin | Cephalexin | 48 | 30 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 32 |
| Amitriptyline Hcl | Amitriptyline Hcl | 47 | 14 |
| Celecoxib | Celecoxib | 47 | 13 |
| Metformin Hcl Er | Metformin Hcl | 47 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 46 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 42 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 41 | suppressed |
| Estradiol | Estradiol | 40 | 13 |
| Ibuprofen | Ibuprofen | 39 | 11 |
| Clonidine Hcl | Clonidine Hcl | 38 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 38 | 11 |
| Promethazine Hcl | Promethazine Hcl | 37 | suppressed |
| Repatha Sureclick | Evolocumab | 37 | suppressed |
| Telmisartan | Telmisartan | 37 | suppressed |
| Atenolol | Atenolol | 36 | 11 |
| Donepezil Hcl | Donepezil Hcl | 35 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 35 | 11 |
| Nitroglycerin | Nitroglycerin | 34 | 16 |
| Trulicity | Dulaglutide | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Irbesartan | Irbesartan | 32 | suppressed |
| Lansoprazole | Lansoprazole | 31 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 30 | suppressed |
| Testosterone | Testosterone | 30 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 30 | suppressed |
| Nystatin | Nystatin | 29 | suppressed |
| Linzess | Linaclotide | 28 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 27 | suppressed |
| Colchicine | Colchicine | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Nateglinide | Nateglinide | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Vraylar | Cariprazine Hcl | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Lovastatin | Lovastatin | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Glipizide | Glipizide | 20 | suppressed |
| Jardiance | Empagliflozin | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 12 |
| Bumetanide | Bumetanide | 19 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | 18 |
| Ramelteon | Ramelteon | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 13 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 17 | 17 |
| Risperidone | Risperidone | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 11 |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Lidocaine | Lidocaine | 16 | suppressed |
| Metronidazole | Metronidazole | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 15 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 15 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 14 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 12 |
| Memantine Hcl | Memantine Hcl | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Ramipril | Ramipril | 14 | suppressed |
| Xtampza Er | Oxycodone Myristate | 14 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Calcipotriene | Calcipotriene | 12 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 11 | suppressed |
| Meperidine Hcl | Meperidine Hcl | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $39.52 · 2 records | CSL Behring | Hizentra, Ozempic, Rybelsus | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error